Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis
Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan Mendelsohn, Jeffrey Parno, Kenneth Gordon
Abstract not available.
Disclosures: Study sponsored by SUN PHARMA.
Copyright SKIN 2018
Abstract - 234 Poster PDF - 74
- There are currently no refbacks.